# Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

> **NCT04617561** · PHASE4 · UNKNOWN · sponsor: **West China Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Hepatitis, Autoimmune
- Primary Biliary Cholangitis

## Interventions

- **DRUG:** Ursodeoxycholic acid
- **DRUG:** Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)

## Key facts

- **NCT ID:** NCT04617561
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04617561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04617561, "Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04617561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*